Global Transdermal Drug Delivery System Market by Manufacturers, Regions, Type and Application, Forecast to 2025

In this report,in the last several years, global market of Transdermal Drug Delivery System developed rapidly, with an average sales growth rate of 13.4%. In 2016, global revenue of Transdermal Drug Delivery System was nearly 8000 million USD; the actual production is about 13300 million units.

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. The unprecedented global shift in the adoption of unhealthy lifestyles is to be responsible for the high prevalence of chronic diseases, such as cancer and diabetes, which is expected to drive the clinical urgency to incorporate transdermal drug delivery systems in the future treatments. Moreover, the rising geriatric population base, which is highly susceptible to developing the aforementioned chronic diseases are expected to propel the demand for highly efficacious pharmacological drugs.

The classification of Transdermal Drug Delivery System includes Fentanyl, Nitroglycerin, Estradiol, Nicotine and Other, and the revenue proportion of Fentanyl in 2016 was about 31%.

Transdermal Drug Delivery System can be used for OTC and Rx. The most proportion of Transdermal Drug Delivery System is OTC, and the sales proportion was about 83% in 2016.

Market competition is intense. Hisamitsu, Mylan, Johnson & Johnson, Actavis, etc. are the leaders of the industry.

North America was the largest sales place, with revenue market share nearly 41% in 2016. Following North America, Europe is the second largest sales place. China and Japan are also important sales regions for Transdermal Drug Delivery System.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Transdermal Drug Delivery System in these regions, from 2014 to 2026 (forecast), covering
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Transdermal Drug Delivery System market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
UCB
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
Other
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Transdermal Drug Delivery System for each application, including
OTC
Rx

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Transdermal Drug Delivery System Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Transdermal Drug Delivery System Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Fentanyl Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Nitroglycerin Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Estradiol Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.4 Nicotine Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.5 Other Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Transdermal Drug Delivery System Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Transdermal Drug Delivery System Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Transdermal Drug Delivery System Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Transdermal Drug Delivery System Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Transdermal Drug Delivery System Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Transdermal Drug Delivery System Market Assessment by Type
8.1 Asia Pacific Transdermal Drug Delivery System Market Assessment by Application (Consumption and Market Share)
8.2 North America Transdermal Drug Delivery System Market Assessment by Application (Consumption and Market Share)
8.3 Europe Transdermal Drug Delivery System Market Assessment by Application (Consumption and Market Share)
8.4 South America Transdermal Drug Delivery System Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Transdermal Drug Delivery System Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Hisamitsu
9.1.1 Hisamitsu Profiles
9.1.2 Hisamitsu Product Portfolio
9.1.3 Hisamitsu Transdermal Drug Delivery System Business Performance
9.1.4 Hisamitsu Transdermal Drug Delivery System Business Development and Market Status
9.2 Mylan
9.2.1 Mylan Profiles
9.2.2 Mylan Product Portfolio
9.2.3 Mylan Transdermal Drug Delivery System Business Performance
9.2.4 Mylan Transdermal Drug Delivery System Business Development and Market Status
9.3 GSK
9.3.1 GSK Profiles
9.3.2 GSK Product Portfolio
9.3.3 GSK Transdermal Drug Delivery System Business Performance
9.3.4 GSK Transdermal Drug Delivery System Business Development and Market Status
9.4 Novartis
9.4.1 Novartis Profiles
9.4.2 Novartis Product Portfolio
9.4.3 Novartis Transdermal Drug Delivery System Business Performance
9.4.4 Novartis Transdermal Drug Delivery System Business Development and Market Status
9.5 Teve (Actavis)
9.5.1 Teve (Actavis) Profiles
9.5.2 Teve (Actavis) Product Portfolio
9.5.3 Teve (Actavis) Transdermal Drug Delivery System Business Performance
9.5.4 Teve (Actavis) Transdermal Drug Delivery System Business Development and Market Status
9.6 Johnson & Johnson
9.6.1 Johnson & Johnson Profiles
9.6.2 Johnson & Johnson Product Portfolio
9.6.3 Johnson & Johnson Transdermal Drug Delivery System Business Performance
9.6.4 Johnson & Johnson Transdermal Drug Delivery System Business Development and Market Status
9.7 UCB
9.7.1 UCB Profiles
9.7.2 UCB Product Portfolio
9.7.3 UCB Transdermal Drug Delivery System Business Performance
9.7.4 UCB Transdermal Drug Delivery System Business Development and Market Status
9.8 Teikoku Seiyaku
9.8.1 Teikoku Seiyaku Profiles
9.8.2 Teikoku Seiyaku Product Portfolio
9.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Business Performance
9.8.4 Teikoku Seiyaku Transdermal Drug Delivery System Business Development and Market Status
9.9 Bayer
9.9.1 Bayer Profiles
9.9.2 Bayer Product Portfolio
9.9.3 Bayer Transdermal Drug Delivery System Business Performance
9.9.4 Bayer Transdermal Drug Delivery System Business Development and Market Status
9.10 Lingrui
9.10.1 Lingrui Profiles
9.10.2 Lingrui Product Portfolio
9.10.3 Lingrui Transdermal Drug Delivery System Business Performance
9.10.4 Lingrui Transdermal Drug Delivery System Business Development and Market Status
9.11 Sanofi
9.12 Qizheng
9.13 Endo
9.14 Huarun 999
9.15 Haw Par
9.16 Nichiban
9.17 Mentholatum Company
9.18 Laboratoires Genevrier
9.19 Other
10 World Transdermal Drug Delivery System Market Assessment by Players
10.1 Global Transdermal Drug Delivery System Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Transdermal Drug Delivery System Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Transdermal Drug Delivery System Price (USD/Unit) of Players 2014-2020
10.4 Global Transdermal Drug Delivery System Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Transdermal Drug Delivery System Sales Assessment of Players 2014-2020
11.1.2 North America Transdermal Drug Delivery System Revenue Assessment of Players 2014-2020
11.1.3 North America Transdermal Drug Delivery System Price Assessment of Players 2014-2020
11.1.4 North America Transdermal Drug Delivery System Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Transdermal Drug Delivery System Sales Assessment of Players 2014-2020
11.2.2 Europe Transdermal Drug Delivery System Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Transdermal Drug Delivery System Price Assessment of Players 2014-2020
11.2.4 Europe Transdermal Drug Delivery System Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Transdermal Drug Delivery System Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Transdermal Drug Delivery System Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Transdermal Drug Delivery System Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Transdermal Drug Delivery System Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Transdermal Drug Delivery System Sales Assessment of Players 2014-2020
11.4.2 South America Transdermal Drug Delivery System Revenue Assessment of Players 2014-2020
11.4.3 South America Transdermal Drug Delivery System Price Assessment of Players 2014-2020
11.4.4 South America Transdermal Drug Delivery System Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Transdermal Drug Delivery System Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Transdermal Drug Delivery System Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Transdermal Drug Delivery System Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Transdermal Drug Delivery System Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Transdermal Drug Delivery System Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Transdermal Drug Delivery System Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Transdermal Drug Delivery System Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Transdermal Drug Delivery System Sales by Countries/Regions 2014-2020
12.2.2 North America Transdermal Drug Delivery System Revenue by Countries/Regions 2014-2020
12.2.3 North America Transdermal Drug Delivery System Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Transdermal Drug Delivery System Sales by Countries/Regions 2014-2020
12.3.2 Europe Transdermal Drug Delivery System Revenue by Countries/Regions 2014-2020
12.3.3 Europe Transdermal Drug Delivery System Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Transdermal Drug Delivery System Sales by Countries/Regions 2014-2020
12.4.2 South America Transdermal Drug Delivery System Revenue by Countries/Regions 2014-2020
12.4.3 South America Transdermal Drug Delivery System Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Transdermal Drug Delivery System Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Transdermal Drug Delivery System Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Transdermal Drug Delivery System Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Transdermal Drug Delivery System Sales & Revenue Forecast 2021-2026
14.1 World Transdermal Drug Delivery System Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Transdermal Drug Delivery SystemSales and Market Share by Regions
14.1.2 World Transdermal Drug Delivery SystemRevenue and Market Share by Regions
15 Asia Transdermal Drug Delivery System Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Fentanyl
15.1.2 Nitroglycerin
15.1.3 Estradiol
15.1.4 Nicotine
15.1.5 Other
15.2 Consumption Forecast by Application, 2021-2026
16 North America Transdermal Drug Delivery System Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Fentanyl
16.1.2 Nitroglycerin
16.1.3 Estradiol
16.1.4 Nicotine
16.1.5 Other
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Transdermal Drug Delivery System Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Fentanyl
17.1.2 Nitroglycerin
17.1.3 Estradiol
17.1.4 Nicotine
17.1.5 Other
17.2 Consumption Forecast by Application, 2021-2026
18 South America Transdermal Drug Delivery System Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Fentanyl
18.1.2 Nitroglycerin
18.1.3 Estradiol
18.1.4 Nicotine
18.1.5 Other
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Transdermal Drug Delivery System Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Fentanyl
19.1.2 Nitroglycerin
19.1.3 Estradiol
19.1.4 Nicotine
19.1.5 Other
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Transdermal Drug Delivery System Price (USD/Unit) Trend 2021-2026
20.2 Global Transdermal Drug Delivery System Gross Profit Trend 2021-2026
21 Conclusion